Total Payments
$18,799
2024 Payments
$2,938
Companies
36
Transactions
440
Medicare Patients
26,996
Medicare Billing
$2.4M
Payment Breakdown by Category
Food & Beverage$10,712 (57.0%)
Other$5,250 (27.9%)
Travel$2,713 (14.4%)
Education$124.48 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,712 | 425 | 57.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,250 | 6 | 27.9% |
| Travel and Lodging | $2,713 | 5 | 14.4% |
| Education | $124.48 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $6,171 | 54 | $0 (2024) |
| Medtronic Vascular, Inc. | $4,855 | 42 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $857.25 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $708.58 | 40 | $0 (2023) |
| PFIZER INC. | $540.14 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $532.38 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $491.85 | 22 | $0 (2024) |
| BIOTRONIK INC. | $475.85 | 20 | $0 (2023) |
| Amgen Inc. | $428.74 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $387.55 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,938 | 67 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($1,579) |
| 2023 | $2,283 | 61 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($813.08) |
| 2022 | $3,962 | 56 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($3,248) |
| 2021 | $1,400 | 49 | AstraZeneca Pharmaceuticals LP ($197.44) |
| 2020 | $926.81 | 38 | Medtronic Vascular, Inc. ($310.94) |
| 2019 | $2,997 | 48 | Medtronic Vascular, Inc. ($2,434) |
| 2018 | $2,801 | 54 | Medtronic Vascular, Inc. ($1,882) |
| 2017 | $1,492 | 67 | Medtronic Vascular, Inc. ($227.83) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.90 | General |
| 12/12/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Not Applicable | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: DIABETES | ||||||
| 09/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.48 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Not Applicable | ||||||
| 08/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/05/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $59.03 | General |
| Category: Medical Device | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 7,629 | 10,435 | $2.6M | $532,201 |
| 2022 | 33 | 6,147 | 8,162 | $2.5M | $529,212 |
| 2021 | 32 | 6,225 | 8,353 | $2.8M | $627,713 |
| 2020 | 33 | 6,995 | 9,120 | $3.2M | $667,667 |
Total Patients
26,996
Total Services
36,070
Medicare Billing
$2.4M
Procedure Codes
143
All Medicare Procedures & Services
143 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,125 | 1,419 | $248,325 | $121,634 | 49.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 269 | 269 | $571,356 | $85,462 | 15.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 398 | 401 | $490,022 | $53,707 | 11.0% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 269 | 537 | $148,749 | $49,002 | 32.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 222 | 888 | $101,232 | $37,578 | 37.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 151 | 168 | $37,800 | $21,402 | 56.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 376 | 382 | $343,684 | $19,173 | 5.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 152 | 152 | $46,056 | $16,933 | 36.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 94 | 94 | $35,908 | $15,025 | 41.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,862 | 2,537 | $96,406 | $14,800 | 15.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 1,234 | 1,488 | $138,384 | $14,552 | 10.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 306 | 308 | $113,036 | $14,452 | 12.8% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 168 | 548 | $50,416 | $11,874 | 23.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 67 | 67 | $25,728 | $8,728 | 33.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 108 | 144 | $20,592 | $8,552 | 41.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 70 | 70 | $21,840 | $6,896 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 94 | $11,280 | $4,732 | 42.0% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 49 | 55 | $27,445 | $4,475 | 16.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 69 | 82 | $13,202 | $4,414 | 33.4% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 31 | 182 | $13,468 | $3,584 | 26.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 63 | 63 | $26,775 | $3,460 | 12.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 63 | 70 | $7,280 | $2,734 | 37.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 23 | $4,669 | $2,004 | 42.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $5,729 | $1,314 | 22.9% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 61 | 61 | $5,429 | $1,190 | 21.9% |
About Dr. Gavin Leask, M.D
Dr. Gavin Leask, M.D is a Cardiovascular Disease healthcare provider based in Florence, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548227804.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gavin Leask, M.D has received a total of $18,799 in payments from pharmaceutical and medical device companies, with $2,938 received in 2024. These payments were reported across 440 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($10,712).
As a Medicare-enrolled provider, Leask has provided services to 26,996 Medicare beneficiaries, totaling 36,070 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 143 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Florence, SC
- Active Since 04/28/2006
- Last Updated 04/17/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1548227804
Products in Payments
- LifeVest (Device) $6,171
- ELIQUIS (Drug) $777.87
- XARELTO (Drug) $708.58
- Azure (Device) $650.10
- LEQVIO (Drug) $446.49
- ENTRESTO (Drug) $410.76
- VERQUVO (Drug) $387.55
- FARXIGA (Drug) $383.80
- VITALPATCH RTM (Device) $280.61
- Repatha (Biological) $264.80
- CareLink (Device) $239.69
- (5091) Amb Mon & Diag Und (Device) $205.49
- Reveal LINQ (Device) $165.99
- WATCHMAN FLX (Device) $160.58
- Corlanor (Drug) $156.60
- VYNDAQEL (Drug) $147.65
- JARDIANCE (Drug) $141.86
- Micra (Device) $141.60
- XEOMIN (Biological) $139.57
- MULTAQ (Drug) $137.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Florence
Dr. Jeffrey Reichard, M.d, M.D
Cardiovascular Disease — Payments: $83,451
Cardiovascular Disease $83,451
Anil Om, M.d, M.D
Cardiovascular Disease — Payments: $60,552
Cardiovascular Disease $60,552
Dr. Therese Lango, Md, MD
Cardiovascular Disease — Payments: $37,405
Cardiovascular Disease $37,405
Dr. Anand Mishra, M.d, M.D
Cardiovascular Disease — Payments: $34,384
Cardiovascular Disease $34,384
Dr. Brian Blaker, Md, MD
Cardiovascular Disease — Payments: $23,276
Cardiovascular Disease $23,276
Prabal Guha, M.d, M.D
Cardiovascular Disease — Payments: $15,809
Cardiovascular Disease $15,809